Literature DB >> 11532559

Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions.

E J Pretell1, H H García, R H Gilman, H Saavedra, M Martinez.   

Abstract

A recently described one-day regimen of praziquantel (PZQ) therapy for neurocysticercosis (NCC), three doses of 25 mg/k given at 2 h intervals, was applied in eight patients with viable NCC cysts without any evidence of inflammation. Resolution of lesions in computed tomography (CT) was observed in all five patients with a single cyst, whereas all cysts survived in three patients with multiple brain parasites. One-day praziquantel is a good regimen for patients with a single viable brain cysticercus but is poorly effective for multiple cysts.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532559     DOI: 10.1016/s0303-8467(01)00137-8

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  11 in total

1.  Neurocysticercosis.

Authors:  Oscar H Del Brutto
Journal:  Neurohospitalist       Date:  2014-10

Review 2.  Diagnosis and treatment of neurocysticercosis.

Authors:  Theodore E Nash; Hector H Garcia
Journal:  Nat Rev Neurol       Date:  2011-09-13       Impact factor: 42.937

Review 3.  Clinical symptoms, diagnosis, and treatment of neurocysticercosis.

Authors:  Hector H Garcia; Theodore E Nash; Oscar H Del Brutto
Journal:  Lancet Neurol       Date:  2014-11-10       Impact factor: 44.182

4.  Neurocysticercosis.

Authors:  Pratibha Singhi
Journal:  Ther Adv Neurol Disord       Date:  2011-03       Impact factor: 6.570

Review 5.  Taenia solium cysticercosis.

Authors:  Héctor H García; Armando E Gonzalez; Carlton A W Evans; Robert H Gilman
Journal:  Lancet       Date:  2003-08-16       Impact factor: 79.321

6.  Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel?

Authors:  Hector H Garcia
Journal:  Expert Rev Anti Infect Ther       Date:  2008-06       Impact factor: 5.091

Review 7.  Current consensus guidelines for treatment of neurocysticercosis.

Authors:  Hector H García; Carlton A W Evans; Theodore E Nash; Osvaldo M Takayanagui; A Clinton White; David Botero; Vedantam Rajshekhar; Victor C W Tsang; Peter M Schantz; James C Allan; Ana Flisser; Dolores Correa; Elsa Sarti; Jon S Friedland; S Manuel Martinez; Armando E Gonzalez; Robert H Gilman; Oscar H Del Brutto
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

Review 8.  Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management.

Authors:  Andrea Sylvia Winkler
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

Review 9.  Neurocysticercosis: a review.

Authors:  Oscar H Del Brutto
Journal:  ScientificWorldJournal       Date:  2012-01-04

Review 10.  Managing neurocysticercosis: challenges and solutions.

Authors:  Yannick Fogoum Fogang; Abdoul Aziz Savadogo; Massaman Camara; Dènahin Hinnoutondji Toffa; Anna Basse; Adjaratou Djeynabou Sow; Mouhamadou Mansour Ndiaye
Journal:  Int J Gen Med       Date:  2015-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.